Results 31 to 40 of about 33,758 (288)

Radiation-induced nausea and vomiting: a comparison between MASCC/ESMO, ASCO, and NCCN antiemetic guidelines

Supportive Care in Cancer, 2019
PurposeRadiation-induced nausea and vomiting (RINV) can affect 50–80% of patients undergoing radiotherapy and negatively impacts quality of life. This review aimed to compare the most recent RINV antiemetic guidelines produced by the Multinational ...
Erin McKenzie, Pearl Zaki, S. Raman, R. Olson, Thomas McFarlane, C. DeAngelis, Stephanie Chan, W. Pidduck, Yasmeen Razvi, A. Bushehri, E. Chow   +10 more
semanticscholar   +1 more source

Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis.

The Oncologist, 2018
BACKGROUND It is important to control chemotherapy-induced nausea and vomiting (CINV) to maintain dose intensity and patients' quality of life. The National Comprehensive Cancer Network guidelines suggest combination therapy of antiemetic agents.
Takamichi Yokoe, T. Hayashida, A. Nagayama, Ayako Nakashoji, Hinako Maeda, T. Seki, Maiko Takahashi, T. Takano, T. Abe, Y. Kitagawa   +9 more
semanticscholar   +1 more source

Progression of lipase activity and pancreatic lipase immunoreactivity in dogs hospitalized for acute pancreatitis and correlation with clinical features

Journal of Veterinary Internal Medicine, Volume 37, Issue 1, Page 70-79, January/February 2023., 2023
Abstract Background Lipase activity and pancreatic lipase immunoreactivity (PLI) have not been compared in dogs hospitalized for acute pancreatitis (AP). Objectives To describe the progression of lipase activity and PLI, and correlations with clinicopathologic features in dogs with AP. Animals Thirty‐nine dogs with AP based on clinical signs and lipase
Claudia Cueni, Natalie Hofer‐Inteeworn, Claudia Kümmerle‐Fraune, Claudia Müller, Peter Hendrik Kook   +4 more
wiley   +1 more source

Clinical and clinicopathological features and outcomes of cats with suspected dietary induced pancytopenia

Journal of Veterinary Internal Medicine, Volume 37, Issue 1, Page 126-132, January/February 2023., 2023
Abstract Background After a strong epidemiological link to diet was established in an outbreak of pancytopenia in cats in spring 2021 in the United Kingdom, 3 dry diets were recalled. Concentrations of the hemato‐ and myelotoxic mycotoxins T‐2, HT‐2 and diacetoxyscirpenol (DAS) greater than the European Commission guidance for dry cat foods were ...
Barbara Glanemann, Karen Humm, Mariana Abreu, Sophie Aspinall, David Buckeridge, Hope Carveth, Hannah Darcy, Jessica Florey, Polly Frowde, Isuru Gajanayake, Kate Green, Emma Holmes, Alenka Hrovat, Anne‐Katherine Jasensky, Bryn A Jones, Vasiliki Lantzaki, Eve JY Lo, Kirsty MacDonald, Kevin O'Brien, Alejandro Suárez‐Bonnet, Nele Van den Steen, Balazs Szladovits, Annelies Willems, Helen Wilson   +23 more
wiley   +1 more source

Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting: A Review to Identify the Best Way to Administer the Drug

Current Oncology, 2022
Common treatment methods for malignant tumors include surgery, chemotherapy, radiotherapy, immunotherapy, targeted therapy, etc., among which chemotherapy plays an important role.
Xiao-Ling Zhang, Jie-Er Ying
doaj   +1 more source

Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients

Al-Mustansiriyah Journal of Pharmaceutical Sciences, 2023
Background:Chemotherapy-caused nausea and vomiting is a health problem in cancer patients. Olanzapine is used with serotonin receptor antagonists plus dexamethasone post Neurokinin 1 receptor antagonists as the antiemetic.
Ghufran salah ahmed, khadim ali khadim2, nabeel mudheher talib   +2 more
doaj   +1 more source

Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.

Cochrane Database of Systematic Reviews, 2016
BACKGROUND Nausea and vomiting remain a problem for children undergoing treatment for malignancies despite new antiemetic therapies. Optimising antiemetic regimens could improve quality of life by reducing nausea, vomiting, and associated clinical ...
R. Phillips, A. Friend, F. Gibson, Elizabeth Houghton, S. Gopaul, J. Craig, B. Pizer   +6 more
semanticscholar   +1 more source

Adherence to guidelines on prophylaxis of chemotherapy-induced nausea and vomiting in the National Cancer Institute, Sudan

South African Journal of Oncology, 2017
Objective: To evaluate the adherence to American Society of Clinical Oncology (ASCO) guidelines for antiemetic prophylaxis of chemotherapy-induced nausea and vomiting and assess the outcomes of the prescribed antiemetic drugs. Methods: This prospective,
Moawia M.A. Elhassan, Arwa A.S.A. Ali, Mohamed O.M. Elmustafa   +2 more
doaj   +1 more source

Antiemetic use among pregnant women in the United States: the escalating use of ondansetron

Pharmacoepidemiology and Drug Safety, 2017
To examine ondansetron use in pregnancy in the context of other antiemetic use among a large insured United States population of women delivering live births.
L. Taylor, Steven T. Bird, L. Sahin, M. Tassinari, P. Greene, M. Reichman, S. Andrade, K. Haffenreffer, S. Toh   +8 more
semanticscholar   +1 more source

New antiemetic drugs

Annals of Oncology, 2006
Important progress in the prophylaxis of chemotherapy-induced acute and delayed emesis has been achieved but some fundamental needs still remain that requires new, efficacious antiemetic drugs.A critical review of the results of published studies of aprepitant, a new NK1 receptor antagonist, and of palonosetron, a 5-HT3 receptor antagonist with a ...
Roila F, Fatigoni S
openaire   +3 more sources